![New Guideline for Using Lab Tests to Improve Cancer Treatment](https://www.g2intelligence.com/wp-content/uploads/2022/09/Oct22.DTET_.Immunology-iStock-1800x1250-1-1080x675.jpg)
New Guideline for Using Lab Tests to Improve Cancer Treatment
The new CAP guidance addresses use of immune checkpoint inhibitors for evaluating and treating patients with specific cancers.
The new CAP guidance addresses use of immune checkpoint inhibitors for evaluating and treating patients with specific cancers.
A recent study shows that the disease was detected sooner in high-risk individuals who underwent screening than those who did not.
The new guidelines will likely prove highly influential with oncologists and payors.
A newly finalized local coverage determination from MAC Palmetto GBA sets out coverage criteria for two applications of these tests.
Collaboration between several key pharmaceutical companies looks to remove barriers for cancer patients to improve treatment selection.